Beau Webber, PhD profile page

Associate Professor

at University of Minnesota

Beau R. Webber, PhD, is an associate professor in the Department of Pediatrics, Division of Hematology and Oncology at the University of Minnesota. Webber led early efforts implementing targeted nucleases for gene editing in primary human T cells and published seminal studies using Cas9 base editors for highly efficient, multiplex editing in primary human T cells. As a junior faculty he led the development and translation of a first-in-human clinical trial using CRISPR engineered tumor infiltrating lymphocytes for the treatment of gastrointestinal (GI) cancer. Webber’s laboratory is currently focused on synergizing genome engineering, stem cell biology, and adoptive cellular therapy to develop novel treatments for genetic disease and cancer.

Education

University of Minnesota

Got a Question for Beau Webber, PhD?

Get in touch using the contact form linked here and we'll get back to you shortly.

Content Written By, Reviewed By, or Featuring Beau Webber, PhD

Total: 1

Article

Manipulating Tumor-Infiltrating Lymphocytes for Cancer Therapy

CRISPR-edited tumor-infiltrating lymphocytes are emerging as a promising alternative to CAR T-cell therapy for solid cancers. Dr. Beau Webber explores the process behind this approach, and the results of a first-in-human trial.